For the Inventor, By the Inventor

Enter assignee name

Maple Grove, MN, United States of America

Coaxia, Inc.

USPTO Granted Patents = 49

% Expired Patents = 42.9

Forward Citations = 4,946

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Denise R Barbut (49 out of 94 patents)

Jon St Germain (9 out of 42 patents)

Peter Trexler Keith (6 out of 165 patents)

4. Steven Wayne Berhow (5 out of 13 patents)

5. Russel H Patterson (4 out of 5 patents)

6. Mark-Hein Heinemann (3 out of 4 patents)

7. Joel R Munsinger (2 out of 22 patents)

Core Competencies:

Cerebral Blood Flow

Flow Reversal

Distal Embolization

Aortic Occlusion

Cerebral Perfusion

Medical Devices

Electrical Nerve Stimulation

Thromboembolic Material

Intravascular Methods

Cooling Device

Selective Perfusion

Collateral Blood Flow

49 patents: Sort by Forward Citations

1. 8221383 - Devices and methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2012-07-17),

2. 8137374 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2012-03-20),

3. 8034043 - Devices and methods for preventing distal embolization using flow reversal by partial occlusion of the brachiocephalic artery (2011-10-11),

4. 7993324 - Cerebral perfusion augmentation (2011-08-09),

5. 7927268 - Counterpulsation device with increased volume-displacement efficiency and methods of use (2011-04-19),

6. 7867195 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2011-01-11),

7. 7635376 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2009-12-22),

8. 7468027 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2008-12-23),

9. 7458980 - Devices and methods for preventing distal embolization using flow reversal in arteries having collateral blood flow (2008-12-02),

10. 7452352 - Methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2008-11-18),

11. 7374561 - Devices and methods for preventing distal embolization during interventional procedures (2008-05-20),

12. 7340298 - Enhancement of cerebral blood flow by electrical nerve stimulation (2008-03-04),

13. 7166097 - Cerebral perfusion augmentation (2007-01-23),

14. 7150736 - Cerebral perfusion augmentation (2006-12-19),

15. 6942686 - Regulation of cerebral blood flow by temperature change-induced vasodilatation (2005-09-13),

Company Overview

Coaxia, Inc., based in Maple Grove, MN, specializes in advanced medical technologies aimed at enhancing cerebral perfusion and preventing complications during vascular procedures. The company focuses on innovative solutions such as flow reversal and distal embolization prevention, which are critical in managing thromboembolic events. Their expertise extends to partial aortic occlusion and intravascular spinal perfusion, alongside electrical nerve stimulation and retrograde venous perfusion techniques, contributing to improved patient outcomes in complex medical scenarios.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

49 Patents

#5 in Maple Grove, MN

#198 in Minnesota

#7,150 in US

#14,293 in the World

Maple Grove, MN, United States of America

Coaxia, Inc.

Forward Citations = 4,946

7 inventors:

Denise R Barbut (49 out of 94 patents)

Jon St Germain (9 out of 42 patents)

Peter Trexler Keith (6 out of 165 patents)

4. Steven Wayne Berhow (5 out of 13 patents)

5. Russel H Patterson (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Coaxia, Inc.. Retrieved from https://idiyas.com/company/coaxia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…